HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Umemura Selected Research

NEPP11 compound

10/2009GIF-0173 protects against cerebral infarction through DP1 receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Umemura Research Topics

Disease

12Stroke (Strokes)
05/2018 - 10/2002
10Hemorrhage
05/2022 - 04/2002
8Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2015 - 06/2002
7Thrombosis (Thrombus)
01/2022 - 04/2002
6Ischemic Stroke
05/2022 - 11/2004
6Infections
01/2020 - 09/2011
5Atherosclerosis
07/2022 - 01/2017
5Cerebral Infarction
01/2020 - 08/2002
5Ischemia
01/2011 - 04/2002
4Brain Ischemia (Cerebral Ischemia)
01/2016 - 04/2004
3Hypercholesterolemia
10/2022 - 12/2021
3Atherosclerotic Plaque (Atheroma)
04/2018 - 11/2014
3Inflammation (Inflammations)
01/2017 - 03/2009
3Reperfusion Injury
01/2016 - 10/2002
3Cerebral Hemorrhage
08/2005 - 04/2002
2Neoplasms (Cancer)
06/2021 - 08/2010
2Infarction (Infarctions)
01/2020 - 10/2009
2Aneurysm (Aneurysms)
01/2018 - 09/2015
2Rupture
01/2018 - 02/2002
2Brain Injuries (Brain Injury)
12/2015 - 10/2005
2Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2012 - 01/2011
2Arteriosclerosis
07/2011 - 03/2009
2Gastroesophageal Reflux (GERD)
04/2011 - 07/2009
2Hyperplasia
09/2005 - 09/2005
1Fibrosis (Cirrhosis)
10/2022
1Non-alcoholic Fatty Liver Disease
10/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2022
1Hemangioma (Angioma)
06/2022
1Hypotension (Low Blood Pressure)
06/2022
1Bradycardia
06/2022
1Hypoglycemia (Reactive Hypoglycemia)
06/2022
1Thrombotic Stroke
05/2022
1Myocardial Infarction
05/2022
1Autistic Disorder (Autism)
01/2022
1Autism Spectrum Disorder
01/2022
1Intracranial Embolism
01/2022
1Thyroid Nodule (Nodule, Thyroid)
06/2021
1Hyperthyroidism
06/2021
1Dental Caries (Decay, Dental)
05/2018
1Aortic Dissection
04/2018
1Hyperlipidemias (Hyperlipidemia)
04/2018
1Thoracic Aortic Aneurysm
04/2018

Drug/Important Bio-Agent (IBA)

8Tissue Plasminogen Activator (Alteplase)FDA Link
01/2016 - 06/2002
7Matrix Metalloproteinases (MMPs)IBA
01/2016 - 02/2002
6Pharmaceutical PreparationsIBA
01/2018 - 04/2003
5Neuroprotective AgentsIBA
10/2009 - 02/2003
4Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2011 - 04/2002
3Apolipoproteins E (ApoE)IBA
12/2021 - 01/2017
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2018 - 04/2004
3CollagenIBA
05/2018 - 09/2011
3LipidsIBA
04/2018 - 11/2014
3Proton Pump InhibitorsIBA
04/2017 - 07/2009
3LigandsIBA
01/2015 - 09/2005
3Heparin (Liquaemin)FDA LinkGeneric
08/2005 - 04/2002
2CytokinesIBA
10/2022 - 10/2005
2PlasminogenIBA
10/2022 - 12/2021
2CholesterolIBA
07/2022 - 02/2002
2oxidized low density lipoproteinIBA
12/2021 - 01/2018
2Carrier Proteins (Binding Protein)IBA
05/2018 - 09/2011
2LDL CholesterolIBA
04/2018 - 01/2018
2ApolipoproteinsIBA
04/2018 - 01/2018
2LDL Receptors (LDL Receptor)IBA
01/2018 - 12/2015
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2018 - 11/2005
2Pancreatic Elastase (Elastase)IBA
01/2018 - 09/2015
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 04/2017
2Coloring Agents (Dyes)IBA
09/2015 - 11/2014
2Cytochrome P-450 CYP2C19IBA
08/2014 - 07/2009
2sitafloxacinIBA
03/2014 - 01/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2005 - 11/2004
2P-SelectinIBA
09/2005 - 09/2005
2Rose BengalIBA
04/2003 - 04/2002
1Tranexamic Acid (AMCA)FDA Link
10/2022
1Streptozocin (Streptozotocin)FDA Link
10/2022
1Tyrosine Kinase InhibitorsIBA
07/2022
1Dasatinib (BMS 354825)FDA Link
07/2022
1Propranolol (Inderal)FDA LinkGeneric
06/2022
1Prasugrel HydrochlorideFDA Link
05/2022
1Clopidogrel (Plavix)FDA Link
05/2022
1Oxytocin (Pitocin)FDA LinkGeneric
01/2022
1Lipoproteins (Lipoprotein)IBA
12/2021
1Cyclic AMP (AMP, Cyclic)IBA
06/2021
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2021
1Codon (Codons)IBA
06/2021
1Anti-Infective Agents (Microbicides)IBA
01/2020
1Bromodeoxyuridine (BrdU)IBA
01/2020
1Clarithromycin (Biaxin)FDA LinkGeneric
01/2020
1Angiotensin IIIBA
04/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2018
1Desoxycorticosterone (Deoxycorticosterone)IBA
01/2018
1Apolipoprotein B-100 (Apo B 100)IBA
01/2018
1Apolipoprotein B-48IBA
01/2018

Therapy/Procedure

8Therapeutics
06/2022 - 10/2002
5Thrombolytic Therapy
01/2022 - 04/2002
2Aftercare (After-Treatment)
05/2022 - 07/2009
2Intravenous Injections
01/2016 - 11/2014
2Transplantation
08/2010 - 03/2009
1Lasers (Laser)
01/2022
1Thrombectomy
01/2022
1Thyroidectomy
06/2021
1Exercise Therapy (Therapy, Exercise)
01/2020